This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 1994 Nov:4 Suppl 1:98-9; discussion 100-1.

The National Cancer Institute Multi-Screening Trial

P Prorok¹

Affiliations

PMID: 8853500

The National Cancer Institute Multi-Screening Trial

P Prorok. Can J Oncol. 1994 Nov.

. 1994 Nov:4 Suppl 1:98-9; discussion 100-1.

Author

P Prorok¹

Affiliation

¹ Division of Cancer Prevention and Control, National Cancer Institute, Bethesda, Maryland, USA.

PMID: 8853500

No abstract available

PubMed Disclaimer

Similar articles

Prostate Cancer Screening in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial: findings from the initial screening round of a randomized trial.
Andriole GL, Levin DL, Crawford ED, Gelmann EP, Pinsky PF, Chia D, Kramer BS, Reding D, Church TR, Grubb RL, Izmirlian G, Ragard LR, Clapp JD, Prorok PC, Gohagan JK; PLCO Project Team. Andriole GL, et al. J Natl Cancer Inst. 2005 Mar 16;97(6):433-8. doi: 10.1093/jnci/dji065. J Natl Cancer Inst. 2005. PMID: 15770007 Clinical Trial.
Update of the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial.
Andriole GL. Andriole GL. Recent Results Cancer Res. 2014;202:53-7. doi: 10.1007/978-3-642-45195-9_6. Recent Results Cancer Res. 2014. PMID: 24531777
Prostate cancer screening in the prostate, lung, colorectal and ovarian cancer screening trial of the National Cancer Institute.
Gohagan JK, Prorok PC, Kramer BS, Cornett JE. Gohagan JK, et al. J Urol. 1994 Nov;152(5 Pt 2):1905-9. doi: 10.1016/s0022-5347(17)32412-6. J Urol. 1994. PMID: 7523735 Clinical Trial.
Detection of prostate cancer: the impact of the European Randomized Study of Screening for Prostate Cancer (ERSPC).
Schröder FH. Schröder FH. Can J Urol. 2005 Feb;12 Suppl 1:2-6; discussion 92-3. Can J Urol. 2005. PMID: 15780157 Review.
The prostate, lung, colorectal, and ovarian cancer screening trial and its associated research resource.
Zhu CS, Pinsky PF, Kramer BS, Prorok PC, Purdue MP, Berg CD, Gohagan JK. Zhu CS, et al. J Natl Cancer Inst. 2013 Nov 20;105(22):1684-93. doi: 10.1093/jnci/djt281. Epub 2013 Oct 10. J Natl Cancer Inst. 2013. PMID: 24115361 Free PMC article. Review.

See all similar articles

Cited by

Physician perspectives on the importance of facts men ought to know about prostate-specific antigen testing.
Chan EC, Vernon SW, Haynes MC, O'Donnell FT, Ahn C. Chan EC, et al. J Gen Intern Med. 2003 May;18(5):350-6. doi: 10.1046/j.1525-1497.2003.20626.x. J Gen Intern Med. 2003. PMID: 12795733 Free PMC article.
Screening for prostate cancer.
Ilic D, Neuberger MM, Djulbegovic M, Dahm P. Ilic D, et al. Cochrane Database Syst Rev. 2013 Jan 31;2013(1):CD004720. doi: 10.1002/14651858.CD004720.pub3. Cochrane Database Syst Rev. 2013. PMID: 23440794 Free PMC article.
Informed consent for cancer screening with prostate-specific antigen: how well are men getting the message?
Chan EC, Vernon SW, O'Donnell FT, Ahn C, Greisinger A, Aga DW. Chan EC, et al. Am J Public Health. 2003 May;93(5):779-85. doi: 10.2105/ajph.93.5.779. Am J Public Health. 2003. PMID: 12721144 Free PMC article.
Cultural sensitivity and informed decision making about prostate cancer screening.
Chan EC, Haynes MC, O'Donnell FT, Bachino C, Vernon SW. Chan EC, et al. J Community Health. 2003 Dec;28(6):393-405. doi: 10.1023/a:1026072022853. J Community Health. 2003. PMID: 14620963

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Medical
- MedlinePlus Health Information